ProCE Banner Activity

Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer

Podcast Episodes

In this podcast episode, expert oncologists Aakash Desai, MD, MPH; Narjust Florez, MD; and Paolo Tarantino, MD, and bring their varied experience in lung and breast cancers to an engaging discussion on the development and potential clinical role of HER3-targeted therapy.

Released: November 07, 2023

Share

Faculty

Aakash Desai

Aakash Desai, MD, MPH

Assistant Professor of Medicine 
O'Neal Comprehensive Cancer Center
University of Alabama at Birmingham
Birmingham, Alabama

Narjust Florez

Narjust Florez, MD

Associate Director of The Cancer Care Equity Program
Thoracic Medical Oncologist
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Associate Editor, JAMA Oncology
Boston, Massachusetts

Paolo Tarantino

Paolo Tarantino, MD

Advanced Research Fellow
Harvard Medical School
Department of Breast Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc. 

Daiichi Sankyo, Inc.

Disclosure

Primary Author

Aakash Desai, MD, MPH

Assistant Professor of Medicine 
O'Neal Comprehensive Cancer Center
University of Alabama at Birmingham
Birmingham, Alabama

Aakash Desai, MD: consultant/advisor/speaker: Amgen, AstraZeneca, Foundation Medicine, Sanofi. 

Narjust Florez, MD

Associate Director of The Cancer Care Equity Program
Thoracic Medical Oncologist
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Associate Editor, JAMA Oncology
Boston, Massachusetts

Narjust Florez, MD: consultant/advisor/speaker: AstraZeneca, Bristol-Myers Squibb, DSI, Merck, Neogenomics, Regeneron, Sanofi.

Paolo Tarantino, MD

Advanced Research Fellow
Harvard Medical School
Department of Breast Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Paolo Tarantino, MD: consultant/advisor/speaker: AstraZeneca, Daiichi Sankyo, Genentech, Gilead, Lilly, Roche.